Spese di spedizione:
EUR 72,50
Da: Belgio a: U.S.A.
Spese di spedizione:
EUR 2,37
In U.S.A.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New. Codice articolo 45377076-n
Quantità: 5 disponibili
Da: Grand Eagle Retail, Wilmington, DE, U.S.A.
Hardcover. Condizione: new. Hardcover. Volume 24, entitled Targeted Metallo-Drugs: Design, Development, and Modes of Action, of the series Metal Ions in Life Sciences (MILS), fosters inter-disciplinary research in the vibrant field of Biological Inorganic Chemistry. Inspired by the clinical success of cisplatin as a leading anticancer drug but mindful of the shortcomings associated with its use including dose-limiting toxic side effects and acquired or intrinsic drug resistance, scientists across the globe have been endeavoring to identify new metallo-drugs for therapeutic exploitation. This has led to innovative metallo-drug candidates that (i) enhance cancer cell selectivity, thus reducing toxic side effects, and/or (ii) possess new modes of action to improve efficacy and also target resistance pathways. This and more are captured in MILS- 24 which consists of 12 comprehensive, well-illustrated, and up to date chapters with over 1600 citations, 100 figures, and 10 tables with key contributions from 32 international experts from Europe, Asia, and North and South America. MILS- 24 not only keeps the scientific community abreast of latest developments, it also serves as an invaluable resource to stimulate further research on targeted metallo-drug design and development.It covers anticancer, antimicrobial, antiviral, and other agents, such as those targeting tropical diseases and cyanide poisoning and radiometals in molecular imaging and therapyIt highlights recent metallo-drug developments targeting COVID-19It features advanced spectroscopic methods and metallomics as important tools to elucidate the modes of actions of metallo-drugs This MILS-24 volume provides a comprehensive overview of recent advances in the development of new metal-based drugs as anti-cancer, anti-microbial and anti-viral agents which have been designed specifically to overcome toxic side effects and/or resistance issues associated with current drug treatments. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Codice articolo 9781032223308
Quantità: 1 disponibili
Da: Ria Christie Collections, Uxbridge, Regno Unito
Condizione: New. In. Codice articolo ria9781032223308_new
Quantità: 1 disponibili
Da: GreatBookPricesUK, Castle Donington, DERBY, Regno Unito
Condizione: New. Codice articolo 45377076-n
Quantità: 2 disponibili
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
Hardback. Condizione: New. New copy - Usually dispatched within 4 working days. Codice articolo B9781032223308
Quantità: 1 disponibili
Da: Biblios, Frankfurt am main, HESSE, Germania
Condizione: New. Codice articolo 18395969744
Quantità: 3 disponibili
Da: Speedyhen, London, Regno Unito
Condizione: NEW. Codice articolo NW9781032223308
Quantità: 1 disponibili
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Condizione: New. 2023. 1st Edition. Hardcover. . . . . . Codice articolo V9781032223308
Quantità: 1 disponibili
Da: Revaluation Books, Exeter, Regno Unito
Hardcover. Condizione: Brand New. 1st edition. 369 pages. 9.50x6.50x0.75 inches. In Stock. Codice articolo __1032223308
Quantità: 1 disponibili
Da: AHA-BUCH GmbH, Einbeck, Germania
Buch. Condizione: Neu. Neuware - This MILS-24 volume provides a comprehensive overview of recent advances in the development of new metal-based drugs as anti-cancer, anti-microbial and anti-viral agents which have been designed specifically to overcome toxic side effects and/or resistance issues associated with current drug treatments. Codice articolo 9781032223308
Quantità: 2 disponibili